1350 - Skill-building Workshop for Pediatricians on the Rational Use of Psychotropic Medications in Youth

Saturday, April 23, 2022

10:00 AM – 11:30 AM US MT

Location: Convention Center: 201/203

CE: Live CME: 1.5

Course Number: 1350

Leader(s)

Deborah Davis, PhD (she/her/hers)

Professor
University of Louisville School of Medicine
LOUISVILLE, Kentucky, United States

Co-Leader(s)

W. David Lohr, MD

Professor of Pediatrics, Division of Child Psychiatry and Pediatric Psychology
University of Louisville School of Medicine
Louisville, Kentucky, United States
DA

Dan Arnold, MD

Assistant Professor
University of Louisville, United States
Bethany Wattles, PharmD, MHA (she/her/hers)

Assistant Professor of Pediatrics
University of Louisville School of Medicine
Louisville, Kentucky, United States
Marie Trace, MD

Developmental-Behavioral Pediatrician
Cleveland Clinic Children’s
Avon Lake, Ohio, United States

Participants should be aware of the following financial/non-financial relationships:

Deborah Winders Davis, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

W. David Lohr, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Dan Arnold, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Bethany A. Wattles, PharmD, MHA: ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Marie Trace, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants will gain knowledge of and skills in the decision-making process for rational use of psychotropic medications for children and adolescents. Workshop leaders consist of a multidisciplinary team of clinicians and researchers including two board-certified child psychiatrists, a primary care pediatrician, a clinical pharmacist, and a researcher. The leaders will introduce the concept of “deprescribing” and why it is important to primary care providers. Also, the workshop will describe best practices and review toolkits available to guide this process. Through ongoing interaction with the leaders, participants will work through case studies to determine when deprescribing should be considered and how to initiate, implement, and monitor the process. The workshop will include both large group didactic and interactive activities and small working groups in which participants will develop a deprescribing plan on case studies. The case studies will be presented to the full group with discussion of best practices. The leaders will use a variety of activities including role-playing, interactive audience engagement, and case scenarios for children of different ages and a variety of diagnoses and medication classes. The primary target audience is primary care physicians, trainees, and advanced practice nurses. However, all conference attendees are welcome.